Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB.
<h4>Background</h4>Histone deacetylase (HDAC) inhibitors present an exciting new approach to activate HIV production from latently infected cells to potentially enhance elimination of these cells and achieve a cure. M344, a novel HDAC inhibitor, shows robust activity in a variety of canc...
Guardado en:
Autores principales: | Hao Ying, Yuhao Zhang, Xin Zhou, Xiying Qu, Pengfei Wang, Sijie Liu, Daru Lu, Huanzhang Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a7872b1bddf40378ff6224164645030 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB.
por: Cherukuri Sudhakar, et al.
Publicado: (2009) -
Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.
por: Xiaofei Gao, et al.
Publicado: (2009) -
Positive selection in East Asians for an EDAR allele that enhances NF-kappaB activation.
por: Jarosław Bryk, et al.
Publicado: (2008) -
The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.
por: Virginie Ropars, et al.
Publicado: (2009) -
Hsc70 is a novel interactor of NF-kappaB p65 in living hippocampal neurons.
por: Christin Klenke, et al.
Publicado: (2013)